Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DR26FMDW6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $199,010
Award facts
- Contract value 100% obligated
- $199,009.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $199,009.56 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The award, issued on November 12, 2025, with an ultimate completion date of December 4, 2025, contains no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group is the sole awardee with no identified subcontractors on this delivery order.
This delivery order is issued under DMS Pharmaceutical Group's recently awarded Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. The IDC, valued at $499,999,999 and effective through December 31, 2036, authorizes the Defense Logistics Agency to issue firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense military healthcare facilities worldwide. As part of the broader $30.3 billion PPV-G GEN V acquisition strategy, DMS Pharmaceutical Group serves as a regional prime vendor contractor, supplying an extensive portfolio including specialty pharmaceuticals, biologics, vaccines, and routine medications essential to federal military medical operations.
Quick answers
Who was awarded contract SPE2DR26FMDW6?
SPE2DR26FMDW6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DR26FMDW6 worth?
The government has obligated $199,010 on SPE2DR26FMDW6.
Is contract SPE2DR26FMDW6 an order under another contract?
Yes. SPE2DR26FMDW6 is a delivery order under SPE2DR25D9114, an indefinite delivery contract.
Was contract SPE2DR26FMDW6 competed?
The extent of competition for SPE2DR26FMDW6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award